BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38422307)

  • 1. Progression of Myocardial 18F-FDG Uptake in a Patient with Cardiotoxicity.
    Berenguer DRF; de Moraes Chaves Becker M; de Oliveira Buril R; Bertão PA; Markman Filho B; Brandão SCS
    Arq Bras Cardiol; 2024; 121(2):e20230276. PubMed ID: 38422307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy-induced Cardiac18F-FDG Uptake in Patients with Lymphoma: An Early Metabolic Index of Cardiotoxicity?
    Dourado MLC; Dompieri LT; Leitão GM; Mourato FA; Santos RGG; Almeida Filho PJ; Markman Filho B; Melo MDT; Brandão SCS
    Arq Bras Cardiol; 2022; 118(6):1049-1058. PubMed ID: 35703659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An image processing tool for the detection of anthracycline-induced cardiotoxicity by evaluating the myocardial metabolic activity in [
    Seiffert AP; Gómez-Grande A; Castro-Leal G; Rodríguez A; Palomino-Fernández D; Gómez EJ; Sánchez-González P; Bueno H
    Int J Comput Assist Radiol Surg; 2022 Feb; 17(2):373-383. PubMed ID: 34698987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced myocardial fluorodeoxyglucose uptake following Adriamycin-based therapy: Evidence of early chemotherapeutic cardiotoxicity?
    Borde C; Kand P; Basu S
    World J Radiol; 2012 May; 4(5):220-3. PubMed ID: 22761982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(16):1-167. PubMed ID: 23074467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-FDG PET-Based Imaging of Myocardial Inflammation Predicts a Functional Outcome Following Transplantation of mESC-Derived Cardiac Induced Cells in a Mouse Model of Myocardial Infarction.
    Vasudevan P; Gaebel R; Doering P; Mueller P; Lemcke H; Stenzel J; Lindner T; Kurth J; Steinhoff G; Vollmar B; Krause BJ; Ince H; David R; Lang CI
    Cells; 2019 Dec; 8(12):. PubMed ID: 31835854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(16):1-80. PubMed ID: 23074393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between FDG uptake in the right ventricular myocardium and cancer therapy-induced cardiotoxicity.
    Kim J; Cho SG; Kang SR; Yoo SW; Kwon SY; Min JJ; Bom HS; Song HC
    J Nucl Cardiol; 2020 Dec; 27(6):2154-2163. PubMed ID: 30719656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An increase in myocardial 18-fluorodeoxyglucose uptake is associated with left ventricular ejection fraction decline in Hodgkin lymphoma patients treated with anthracycline.
    Sarocchi M; Bauckneht M; Arboscello E; Capitanio S; Marini C; Morbelli S; Miglino M; Congiu AG; Ghigliotti G; Balbi M; Brunelli C; Sambuceti G; Ameri P; Spallarossa P
    J Transl Med; 2018 Oct; 16(1):295. PubMed ID: 30359253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidental Acute Appendicitis on Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (18F-FDG PET/CT) Imaging: Radiology From a Different Perspective.
    Hamid S; Nausheen S; Ahmed N; Hussain RP; Ihsan N
    Cureus; 2021 Sep; 13(9):e17734. PubMed ID: 34659948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Myocardial Metabolic Abnormalities by 18F-FDG PET/CT and Corresponding Pathological Changes in Beagles with Local Heart Irradiation.
    Yan R; Song J; Wu Z; Guo M; Liu J; Li J; Hao X; Li S
    Korean J Radiol; 2015; 16(4):919-28. PubMed ID: 26175594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial
    Haider A; Bengs S; Schade K; Wijnen WJ; Portmann A; Etter D; Fröhlich S; Warnock GI; Treyer V; Burger IA; Fiechter M; Kudura K; Fuchs TA; Pazhenkottil AP; Buechel RR; Kaufmann PA; Meisel A; Stolzmann P; Gebhard C
    J Clin Med; 2020 Jul; 9(7):. PubMed ID: 32709049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Appearance of aseptic vascular grafts after endovascular aortic repair on [(18)F]fluorodeoxyglucose positron emission tomography/computed tomography.
    Bennett P; Tomas MB; Koch CF; Nichols KJ; Palestro CJ
    World J Radiol; 2023 Aug; 15(8):241-249. PubMed ID: 37662425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance imaging (MRI) for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(15):1-45. PubMed ID: 23074392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined Cardiac Fluorodeoxyglucose-Positron Emission Tomography/Magnetic Resonance Imaging Assessment of Myocardial Injury in Patients Who Recently Recovered From COVID-19.
    Hanneman K; Houbois C; Schoffel A; Gustafson D; Iwanochko RM; Wintersperger BJ; Chan R; Fish JE; Howe KL; Thavendiranathan P
    JAMA Cardiol; 2022 Mar; 7(3):298-308. PubMed ID: 35019953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of pretransplantation positron emission tomography using fluorine 18-fluorodeoxyglucose in patients with aggressive lymphoma treated with high-dose chemotherapy and stem cell transplantation.
    Spaepen K; Stroobants S; Dupont P; Vandenberghe P; Maertens J; Bormans G; Thomas J; Balzarini J; De Wolf-Peeters C; Mortelmans L; Verhoef G
    Blood; 2003 Jul; 102(1):53-9. PubMed ID: 12609836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma: is [18F]FDG-PET a valid alternative to conventional diagnostic methods?
    Spaepen K; Stroobants S; Dupont P; Van Steenweghen S; Thomas J; Vandenberghe P; Vanuytsel L; Bormans G; Balzarini J; De Wolf-Peeters C; Mortelmans L; Verhoef G
    J Clin Oncol; 2001 Jan; 19(2):414-9. PubMed ID: 11208833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging.
    Jerusalem G; Beguin Y; Fassotte MF; Najjar F; Paulus P; Rigo P; Fillet G
    Blood; 1999 Jul; 94(2):429-33. PubMed ID: 10397709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of myocardial 18F-fluorodeoxyglucose positron emission computed tomography in dilated cardiomyopathy and ischemic cardiomyopathy.
    Yamaguchi H; Hasegawa S; Yoshioka J; Uehara T; Hashimoto K; Kusuoka H; Kuzuya T; Hori M; Nishimura T
    Ann Nucl Med; 2000 Feb; 14(1):33-8. PubMed ID: 10770578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.